- Home
- PRPH vs NYC Comparison
PRPH vs NYC Comparison
Compare PRPH & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPH
- NYC
- Stock Information
- Founded
- PRPH 1989
- NYC 2013
- Country
- PRPH United States
- NYC United States
- Employees
- PRPH N/A
- NYC N/A
- Industry
- PRPH Biotechnology: Pharmaceutical Preparations
- NYC Real Estate
- Sector
- PRPH Health Care
- NYC Finance
- Exchange
- PRPH Nasdaq
- NYC Nasdaq
- Market Cap
- PRPH 21.9M
- NYC 25.4M
- IPO Year
- PRPH 1997
- NYC N/A
- Fundamental
- Price
- PRPH $0.28
- NYC $8.05
- Analyst Decision
- PRPH
- NYC
- Analyst Count
- PRPH 0
- NYC 0
- Target Price
- PRPH N/A
- NYC N/A
- AVG Volume (30 Days)
- PRPH 1.3M
- NYC 3.3K
- Earning Date
- PRPH 11-07-2025
- NYC 11-14-2025
- Dividend Yield
- PRPH N/A
- NYC N/A
- EPS Growth
- PRPH N/A
- NYC N/A
- EPS
- PRPH N/A
- NYC N/A
- Revenue
- PRPH $5,588,000.00
- NYC $54,865,000.00
- Revenue This Year
- PRPH $221.82
- NYC $8.40
- Revenue Next Year
- PRPH N/A
- NYC $1.62
- P/E Ratio
- PRPH N/A
- NYC N/A
- Revenue Growth
- PRPH N/A
- NYC N/A
- 52 Week Low
- PRPH $0.22
- NYC $7.20
- 52 Week High
- PRPH $0.93
- NYC $16.30
- Technical
- Relative Strength Index (RSI)
- PRPH 35.09
- NYC 30.14
- Support Level
- PRPH $0.26
- NYC $7.20
- Resistance Level
- PRPH $0.29
- NYC $8.05
- Average True Range (ATR)
- PRPH 0.03
- NYC 0.39
- MACD
- PRPH -0.01
- NYC -0.12
- Stochastic Oscillator
- PRPH 21.42
- NYC 30.15
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.